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There is increasing evidence of adverse health effects due to elevated lithium exposure through drinking
water but the impact on calcium homeostasis is unknown. This study aimed at elucidating if lithium
exposure through drinking water during pregnancy may impair the maternal calcium homeostasis. In a
population-based mother-child cohort in the Argentinean Andes (n¼178), with elevated lithium con-
centrations in the drinking water (5–1660 μg/L), blood lithium concentrations (correlating signiﬁcantly
with lithium in water, urine and plasma) were measured repeatedly during pregnancy by inductively
coupled plasma mass spectrometry and used as exposure biomarker. Markers of calcium homeostasis
included: plasma 25-hydroxyvitamin D3, serum parathyroid hormone (PTH), and calcium, phosphorus
and magnesium concentrations in serum and urine. The median maternal blood lithium concentration
was 25 μg/L (range 1.9–145). In multivariable-adjusted mixed-effects linear regression models, blood
lithium was inversely associated with 25-hydroxyvitamin D3 (6.1 nmol/L [95%CI 9.5; 2.6] for a
25 μg/L increment in blood lithium). The estimate increased markedly with increasing percentiles of 25-
hydroxyvitamin D3. In multivariable-adjusted mixed-effects logistic regression models, the odds ratio of
having 25-hydroxyvitamin D3o30 nmol/L (19% of the women) was 4.6 (95%CI 1.1; 19.3) for a 25 μg/L
increment in blood lithium. Blood lithium was also positively associated with serum magnesium, but not
with serum calcium and PTH, and inversely associated with urinary calcium and magnesium. In con-
clusion, our study suggests that lithium exposure through drinking water during pregnancy may impair
the calcium homeostasis, particularly vitamin D. The results reinforce the need for better control of
lithium in drinking water, including bottled water.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A recently discovered environmental health problem of po-
tential public health relevance is the presence of elevated con-
centrations of lithium in drinking water (Concha et al., 2010; Or-
machea Munoz et al., 2013; Reimann and Birke, 2010). Lithium has
been suggested to be essential for humans (Pickett and O'Dell
1992; Schrauzer, 2002), however, the evidence is weak. On the
other hand, lithium exposure has been associated with impaired
thyroid function in women (Broberg et al., 2011), including preg-
nant women (Harari et al. 2015a), in northern Argentina, where
the lithium concentrations in drinking water range 5–1660 μg/L.
Lithium readily crosses the placenta (Harari et al., 2012) and an
inverse association between maternal blood lithiumInc. This is an open access article u
edicine, Karolinska Institutet,concentrations during pregnancy and birth length has also been
observed (Harari et al., 2015b).
Lithium has long been used in the treatment of bipolar disease
(Grandjean and Aubry, 2009). The side effects of lithium therapy
include impaired calcium homeostasis, often as hyperparathyr-
oidism (McKnight et al., 2012; Shine et al., 2015). Whether lithium
in drinking water can have similar effects in the general popula-
tion is not known. The calcium homeostasis is strictly regulated
because of calcium's important role in bone formation, in-
tracellular signaling and muscle contraction. Parathyroid function
and circulating concentrations of magnesium, phosphorus and
vitamin D are vital parts of this regulation (Brannon and Picciano,
2011).
During pregnancy, deﬁcient vitamin D and elevated para-
thyroid hormone concentrations have been associated with im-
paired maternal and fetal health, specially preeclampsia, infectious
diseases, fetal skeletal development and developmental pro-
gramming (Brannon and Picciano, 2011; Karras et al., 2014).
Therefore, we aim at elucidating the potential impact of lithiumnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ostasis during pregnancy in a mother-child cohort in the Argen-
tinean Andes.2. Methods
2.1. Study population
The study was performed within our mother-child cohort in
San Antonio de los Cobres and surrounding nine small villages in
the Andean part (3180–4070 m above sea level; latitude 24;
about 8000 inhabitants, mostly indigenous) of the Salta province,
northern Argentina (Harari et al., 2015b). The drinking water in
this area, mostly public water supplies, contains varying con-
centrations of lithium (5–1660 μg/L), frequently also arsenic, ce-
sium and boron (Concha et al., 2010; Harari et al., 2015b). All
pregnant women in the study area with an estimated delivery date
between October 2012 and December 2013 were invited to par-
ticipate in the study. Out of a total of 221 pregnant women, 194
became enrolled. We excluded two women who had spontaneous
abortions and 14 who lacked exposure or calcium biomarkers
giving a ﬁnal number of 178 women. More details about the study
area and recruitment of this cohort have been described elsewhere
(Harari et al., 2015b).
2.2. Data and sample collection
This cohort was designed to obtain repeated exposure and
outcomes measures during pregnancy. At the ﬁrst meeting, we
interviewed the pregnant women about age, last menstrual period
(LMP), pre-pregnancy weight, parity, family income, education
level, smoking, alcohol consumption, coca chewing, and personal
and familial history of diseases. We measured height at the ﬁrst
visit. At each visit, we asked about potentially encountered health
problems during pregnancy, collected blood and urine samples,
and measured weight, lean body mass (LBM) and blood pressure
(Harari et al., 2015b). We measured urinary albumin using He-
moCues Albumin 201 System (HemoCue AB, Ängelholm, Sweden)
and calculated the gestational age, pre-pregnancy body mass in-
dex and LBM (Harari et al., 2015b).
Venous blood samples were collected in Trace Elements So-
dium Heparin tubes and in Trace Elements Serum Clot Activator
tubes (Vacuettes; Greiner bio-one, Kremsmünster, Austria). We
fractionated serum and plasma by centrifugation (3000 rpm,
10 min) exactly 15 min after blood withdrawal. Serum samples
were used for analyses of Parathyroid hormone (PTH), calcium,
phosphate, magnesium, boron and albumin. Plasma intended for
analyses of 25-hydroxyvitamin D3 concentrations was carefully
protected from UV-light. Urine was collected in disposable trace
element-free plastic cups and immediately transferred to 20-mL
polyethylene bottles (Zinsser Analytic GMBH, Frankfurt, Germany).
Water samples were collected in 20-mL polyethylene bottles
during the study period. All samples were kept at 20 °C until
transported to Karolinska Institutet, Sweden, where they were
stored at 80 °C until analysis.
2.3. Exposure assessment
The assessment of lithium exposure was based on the con-
centrations in whole blood and we compared those with the
concentrations in urine and drinking water. We were not able to
use serum lithium concentrations as the Trace Elements Serum
Clot Activator tubes were severely contaminated by lithium (Lu
et al., 2015), but in a sub-set (N¼20) of the women we found an
excellent correlation (rs¼0.99) between lithium concentrations inwhole blood and plasma (from non-contaminated tubes). The
plasma lithium concentrations were on average 1.5 times that in
whole blood (range of ratios 1.4–1.6) (Harari, 2015). We also
measured arsenic (urine and water), cesium and boron (blood/
serum, urine and water), as they were also present in the drinking
water in the study area (Concha et al., 2010; Harari et al., 2015b).
All elements were determined using inductively coupled plasma
mass spectrometry (ICP-MS, Agilent 7700x, Agilent Technologies,
Tokyo, Japan), with the collision/reaction cell in no gas mode (li-
thium, boron and cesium) or helium mode (arsenic). Before ana-
lysis, the urine and water samples were diluted 1:10 with 1% nitric
acid (HNO3 65% w/w, ppb-trace analysis grade, Scharlab S.L.,
Sentmenat, Spain). Arsenic metabolites in urine were separated by
high-performance liquid chromatography coupled with hydride
generation and ICP-MS (Harari et al., 2015b). To compensate for
variations in the dilution of urine, we adjusted the element con-
centrations to the mean urinary osmolality (694 mOsm/kg; range
141–1174) (Harari et al., 2015b).
For determination of lithium and cesium in blood and boron in
serum, aliquots (0.2 mL) of the samples were diluted 1:25 with an
alkali solution (1-butanol 2% (w/v), EDTA 0.05% (w/v), triton X-100
0.05% (w/v), NH4OH 1% (w/v)) (Lu et al., 2015). This method pro-
vided a better limit of detection (LOD) and analytical stability for
blood lithium than the conventional acid digestion (Lu et al., 2015).
Three serum samples had boron concentrations below the LOD
(calculated as three times the standard deviation of the blanks)
and those were replaced by LOD/√2. Commercially available re-
ference materials were analyzed with the collected samples to
validate analytical accuracy (Supplemental Table 1).
2.4. Markers of calcium homeostasis
Assessment of calcium metabolism was based on the con-
centrations of serum intact parathyroid hormone (PTH), plasma
25-hydroxyvitamin D3, as well as total concentrations of calcium,
phosphorus and magnesium in serum and urine. Total calcium,
phosphorus and magnesium were analyzed by ICP-MS as de-
scribed above (Harari et al., 2015b; Lu et al., 2015). Analyses of
PTH, 25-hydroxyvitamin D3 (also refer to as “vitamin D3”) and
albumin, were performed at the Department of Clinical Chemistry
at the University Hospitals in Lund and Malmö, Sweden. PTH was
analyzed using a one-step sandwich method with electro-chemi-
luminescence immunoassay (ECLI; Roche Diagnostics, Mannheim,
Germany) and measured subsequently using a Cobass 6000/8000
analyzer system (Roche Diagnostics International Ltd. Switzer-
land). Vitamin D3 concentrations in plasma were measured using
liquid chromatography connected to a triple quadrupole mass
spectrometer (LC-MS/MS, API™ 4000, AB-Sciex, Concord, Ontario,
Canada). Albumin was analyzed using an immunoturbidimetric
method and measured using a Cobass 6000/8000 analyzer system
(Roche Diagnostics International Ltd., Switzerland). As calcium is
mostly bound to albumin in the blood, serum calcium concentra-
tions were adjusted for serum albumin (Payne et al., 1973). Total
and albumin-adjusted serum calcium concentrations were used as
outcomes.
2.5. Statistical analyses
Univariate associations were initially assessed using Spear-
man's rank correlation (rs) or linear mixed-effects regression (for
longitudinal data). We visually evaluated scatter plots of the out-
comes versus exposure measures and covariates. Differences in the
exposure and outcome markers, and covariates across tertiles of
blood lithium were evaluated using Kruskal–Wallis H rank test or
chi square test. We evaluated the associations between lithium
exposure and biomarkers of calcium homeostasis (apparently
Fig. 1. Plasma concentrations of 25-hydroxyvitamin D3 (all observations, n¼269)
by season of sampling. Box layers describe the 75th, 50th and 25th percentiles.
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2nd and 3rd trimesters) using linear mixed-effects regression with
random intercept and maximum likelihood estimation, based on
1–3 measurements per woman, and using linear regression for
data in the 3rd trimester only. For dichotomous outcome variables,
we used mixed-effects logistic regression with random intercept
(for longitudinal analyses) and binomial logistic regression for data
in the 3rd trimester only. We performed quantile regression ana-
lyses in the 3rd trimester based on ﬁve quantiles (5th, 25th, 50th,
75th and 95th) to assess the association of blood lithium on the
whole distribution of the outcomes. Estimates, conﬁdence inter-
vals (CIs), and p-values were based on 500 bootstrap samples.
Wald test was used to test for differences between the estimated
regression coefﬁcients across the quantiles.
Models were adjusted for covariates known to affect the cal-
cium homeostasis or that inﬂuenced the estimates more than 10%.
Initially, (Model 1) we adjusted the models for gestational age
(weeks) and season of sampling (summer/fall/spring/winter), be-
cause these covariates were associated with most of the exposure
and outcome measures. In model 2, we additionally adjusted for
maternal age and urinary arsenic metabolites. The ﬁnal multi-
variable-adjusted model 3 included also serum boron (μg/L), as
this markedly inﬂuenced some of the associations. Maternal edu-
cation level, maternal height, parity, parental monthly income,
coca chewing, hemoglobin concentrations, lean body mass, cesium
exposure and infections during pregnancy as well as ethnicity
(kolla vs. others) did not inﬂuence the associations between blood
lithium and the outcomes. Data on pre-pregnancy weight was
missing for 17.3% of the women and, because this variable did not
alter the coefﬁcients of the various associations (tested by com-
paring coefﬁcients before and after adjustment for weight in the
models with complete data), it was not included in the ﬁnal
models.
Statistical analyses were performed using Stata (StataCorp LP.
2012. Stata Statistical Software: Release 12.1. College Station, TX,
USA) and R (version 3.2.1, (R Core Team, 2015)). All tests were two
sided and p-valueso0.05 were considered statistically signiﬁcant.3. Results
The highest water lithium concentration was observed in the
largest village San Antonio de los Cobres (mean 718 μg/L, range
528–837; n¼58 from one and the same source), as compared with
5.0–324 (n¼83) in the other 9 villages. In spite of the moderate
variation in the lithium concentrations in the public water in the
main village, we observed wide variations in the concentrations of
blood lithium (median 25 mg/L, range 1.9–145 mg/L; n¼178) and
urine lithium (1491 mg/L, 105–4598, n¼178). Still, water lithium
correlated well with blood lithium (rs¼0.40) and urine lithium
(rs¼0.44).
In total, we obtained 269 observations of combined exposure
and outcome measures from the 178 participating women; 31 in
the 1st trimester, 94 in the 2nd and 144 in the 3rd. Only one
woman reported smoking (seldom) and ﬁve used alcohol (very
moderately). Blood lithium correlated strongly with urinary li-
thium (rs¼0.84, po0.001). Both blood lithium and urinary lithium
increased with increasing gestational age, but the concentrations
were not affected by the season of sampling. On the contrary, we
observed a clear variation in the vitamin D3 concentration by the
season of sampling (Fig. 1), but no inﬂuence by gestational age
(p¼0.85).
As shown in Table 1, there were no major differences in the
maternal basic characteristics across tertiles of blood lithium
concentrations (mean concentrations were used for women with
several measurements). All the other exposure biomarkers (in latepregnancy for the purpose of comparison) increased with in-
creasing blood lithium. Serum phosphorus and magnesium in-
creased signiﬁcantly while urinary calcium decreased across the
tertiles of blood lithium (Table 1). The vitamin D3 concentration
did not differ across the tertiles of blood lithium or between the 10
villages (p¼0.49). The overall median vitamin D3 concentration
was 41 nmol/L (mean7SD 44717 nmol/L); and 58% of the wo-
men had vitamin D3 concentrations o50 nmol/L (o20 ng/ml)
and 19% had o30 nmol/L (o10 ng/ml). No woman had abnormal
PTH (47.15pmol/L) or serum magnesium concentrations
(425 mg/L) and only 6 women (4%) had elevated albumin-ad-
justed serum calcium concentrations (410.4 mg/L). The correla-
tion matrix of all biomarkers of exposure and outcomes and basic
characteristics (Supplemental Fig. 1) showed a clear cluster of high
correlations among the exposure markers. Also, calcium and
magnesium in serum and urine were correlated, but not phos-
phorous in serum and urine.
Table 2 shows the linear mixed-effects regression analysis of
the different outcome markers in relation to the maternal blood
lithium concentrations. In the multivariable-adjusted model 2, we
observed inverse associations of blood lithium with vitamin D3,
urinary calcium and magnesium and positive associations with
serum phosphorus. After additional adjustment for serum boron
(fully-adjusted model 3), the associations became stronger for vi-
tamin D3 (Fig. 2) and serum and urinary magnesium, while the
association with serum phosphorus became non-signiﬁcant (Ta-
ble 2). Neither urinary arsenic, nor serum boron, was associated
with any of the calcium markers. The cross-sectional linear re-
gression analyses restricted to data in the 3rd trimester (n¼144)
basically conﬁrmed the longitudinal results, but showed stronger
estimates for the associations between blood lithium and vitamin
D3 and serum and urinary phosphorus (Supplemental Table 2).
Season of sampling remained statistically signiﬁcant in all the
models with vitamin D3. Stratiﬁcation of model 3 by season of
sampling (summer/fall vs. spring/winter) did not reveal any major
differences in the association between lithium exposure and vi-
tamin D3 by season (data not shown). Exclusion of outliers
(475 mg/L, n¼4) did not change the estimates in any of the
models. Restricting the analyses to the women in San Antonio de
los Cobres, who had the highest lithium exposure, gave slightly
stronger estimate for blood lithium and vitamin D3 (9.5 nmol/L,
95%CI 16; 3.0; model 3).
In the multivariable-adjusted mixed-effects logistic regression
(all women), every 25 μg/L increase in blood lithium concentra-
tions was associated with 3.5 higher odds (95%CI 1.0; 12) of having
Table 1
Maternal characteristics at baseline and outcome and exposure measures in late pregnancy by tertiles of mean blood lithium during pregnancya (n¼178).
Tertile 1 Tertile 2 Tertile 3 p-Valueb
(n¼60) (n¼59) (n¼59)
Blood lithium (lg/L) 11 (1.9–18) 25 (19–31) 47 (31–145)
Maternal characteristics at baseline
Maternal age (years) 24 (15–41) 22 (14–37) 24 (13–40) 0.74
Parity (n) 1.0 (0.0–11) 1.0 (0.0–12) 1.0 (0.0–8.0) 0.84
Maternal education level (years) 9.0 (0.0–16) 9.0 (0.0–17) 10 (0.0–15) 0.59
Parental monthly income (ARS) 2150 (0.0–8000) 1550 (0.0–6000) 1000 (0.0–8000) 0.69
Height (cm) 153 (144–169) 153 (144–168) 152 (134–161) 0.11
Pre-pregnancy weight (kg) 53 (40–86) 54 (42–74) 50 (38–77) 0.12
Systolic blood pressure (mmHg) 105 (80–148) 105 (80–130) 100 (80–195) 0.99
Diastolic blood pressure (mmHg) 65 (40–95) 65 (40–90) 70 (45–105) 0.71
Coca chewing (n (%)) 26 (33%) 24 (30) 29 (37%) 0.64
Outcomes in late pregnancy
Serum iPTH (pmol/L) 2.1 (0.65–6.2) 1.8 (0.73–5.4) 1.9 (0.53–5.3) 0.83
Plasma 25(OH)Vitamin D3 (nmol/L) 44 (21–90) 39 (11–102) 37 (13–88) 0.11
Total serum calcium (mg/L) 89 (78–109) 88 (69–101) 88 (78–98) 0.14
Adjusted serum calcium (mg/L)c 97 (83–121) 98 (82–109) 98 (86–114) 0.84
Urinary calcium (mg/L)d 102 (2.1–319) 108 (7.8–375) 68 (1.9–510) 0.015
Serum phosphorus (mg/L) 142 (103-187) 152 (99–195) 154 (98-203) 0.0020
Urinary phosphorus (mg/L)d 376 (65–1106) 377 (160–892) 335 (127–1049) 0.68
Serum magnesium (mg/L) 18 (14–22) 18 (13–21) 19 (15–22) 0.0074
Urinary magnesium (mg/L)d 56 (10–128) 62 (19–131) 54 (9.4–185) 0.24
Urinary albumin (mg/L) 6 (0–710) 6 (0–240) 7 (0–5900) 0.49
Exposure biomarkers in late pregnancy
Urinary lithium (mg/L)d 714 (105–1855) 1460 (671–5185) 2397 (1031–4598) o0.001
Blood cesium (mg/L) 63 (2.5–576) 115 (6.2–711) 142 (11–362) o0.001
Urinary cesium (mg/L)d 278 (14–1748) 474 (26–1696) 603 (17–2248) o0.001
Urinary arsenic (mg/L)d 60 (13–1826) 136 (25–556) 158 (43–2450) o0.001
Serum boron (mg/L) 77 (0.13–262) 133 (0.13–447) 201 (25–658) o0.001
Abbreviations: ARS: Argentinian pesos, iPTH: intact parathyroid hormone.
a Median and range (minimum-maximum) or n(%) are presented by the tertiles of lithium (based on the average concentrations) during pregnancy.
b Comparison across tertiles of lithium based on Kruskal-Wallis rank test or chi square test.
c Serum calcium concentrations were adjusted by serum albumin levels.
d Urinary concentrations were adjusted for the mean urinary osmolality from all urine samples (694 mOsm/Kg).
Table 2
Linear mixed effect models of associations between maternal exposure to lithium through drinking water and concentrations of different markers of calcium homeostasis
during pregnancy (n¼178, observations¼269).
Outcomes Model 1a Model 2b Model 3c
B (95% CI)d p B (95% CI)d p B (95% CI)d p
Intact serum PTH (pmol/L) 0.015 (0.21; 0.18) 0.88 0.029 (0.18; 0.24) 0.78 0.019 (0.25; 0.29) 0.89
Plasma 25(OH)Vitamin D3 (nmol/L) 3.4 (5.8; 1.0) 0.005 3.7 (6.2; 1.2) 0.004 6.1 (9.5; 2.6) 0.001
Total serum calcium (mg/L) 0.84 (1.6; 0.13) 0.020 0.57 (1.3; 0.15) 0.12 0.15 (1.1; 0.84) 0.76
Albumin-adjusted serum calcium (mg/L)e 0.021 (0.093; 0.051) 0.58 0.029 (0.10; 0.046) 0.45 0.016 (0.087; 0.12) 0.76
Urinary calcium (mg/L)f 22 (37; 7.0) 0.004 29 (44; 13) o0.001 29 (51; 7.2) 0.009
Serum phosphorus (mg/L) 4.1 (1.2; 6.9) 0.005 4.4 (1.5; 7.4) 0.004 2.2 (1.9; 6.4) 0.29
Urinary phosphorus (mg/L)f 14 (47; 19) 0.41 18 (53; 17) 0.30 3.7 (52; 45) 0.88
Serum magnesium (mg/L) 0.22 (0.044; 0.48) 0.10 0.19 (0.089; 0.45) 0.19 0.40 (0.008; 0.79) 0.045
Urine magnesium (mg/L)f 3.9 (8.6; 0.81) 0.11 5.7 (11; 0.79) 0.023 8.9 (16; 2.1) 0.010
a Adjusted for: Gestational age (weeks) and season of sampling (summer/fall/spring/winter).
b Additionally adjusted for: Maternal age (years) and urinary arsenic (mg/L). Model for total serum calcium was also adjusted for serum albumin (g/L).
c Additionally adjusted for: Serum boron (mg/L).
d Coefﬁcients are expressed as changes in the outcomes for every 25 μg/L increase in blood lithium concentration.
e Serum calcium concentrations were adjusted by serum albumin levels.
f Urinary concentrations are adjusted for the mean urinary osmolality from all urine samples (694 mOsm/Kg).
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CI 1.1; 19) of having vitamin D3 concentrations o30 nmol/L
(Table 3).
The quantile regression analyses, performed in the 3rd trimester
to explore potential variation in the association across the whole
distribution of vitamin D3 showed higher estimates in the highest
quantiles of vitamin D3. After adjustment for gestational age, seasonof sampling, maternal age, urinary arsenic and serum boron, the
changes per 25 μg/L increment in blood lithiumwere as follows: 5th
percentile: 2.7 nmol/L (95%CI–10; 4.9), 25th: 5.7 (10; 1.4),
50th: 5.0 (12; 1.5), 75th: 8.3 (15; 1.6) and 95th: 17
(23; 10; corresponding to 1 SD; p for trendo0.001).
To investigate the potential involvement of impaired kidney
function in the association between blood lithium and vitamin D3,
Fig. 2. Associations of maternal blood lithium with 25(OH)vitamin D3 concentra-
tions during pregnancy. Dashed lines represent the ﬁtted model of blood lithium
and 25(OH)vitamin D3 concentrations adjusted for gestational age, season of
sampling (summer/fall/spring/winter), maternal age, urinary arsenic and serum
boron.
Table 3
Maternal risk (95% conﬁdence intervals) of having vitamin D3 concentrations
o50 nmol/L or o30 nmol/L in relation to exposure to lithium through drinking
water across pregnancy and in the 3rd trimester.
Cases (n (%)) Odds ratio
(95% CI)a
p-value
25(OH)vitamin D3o50 nmol/L
Across pregnancyb 181 (67) 3.46 (1.040; 11.5) 0.043
Only 3rd trimesterc 100 (70) 3.43 (1.23; 9.55) 0.018
25(OH)vitamin D3o30 nmol/L
Across pregnancyb 57 (21) 4.64 (1.11; 19.3) 0.035
Only 3rd trimesterc 34 (24) 2.98 (1.21; 7.32) 0.017
a Adjusted for: Gestational age (weeks), season of sampling (summer/fall/
spring/winter), maternal age (years), urinary arsenic (mg/L) and serum boron (mg/L).
Odds ratios expressed for every 25 μg/L increase in blood lithium.
b n¼178, observations¼269.
c n¼144.
F. Harari et al. / Environmental Research 147 (2016) 1–7 5we additionally adjusted the linear mixed-effects model 3 for ur-
inary albumin, which resulted in a 23% attenuation of the estimate
(4.7 nmol/L; 95%CI 8.4; 1.0, p¼0.012). Additional adjust-
ment for urinary albumin similarly decreased the association be-
tween lithium and serum magnesium (from 0.40 mg/L (95%CI
0.008, 0.79) to 0.22 mg/L (0.20; 0.64) per 25 μg/L increment of
serum lithium). In addition, blood lithium was associated with
6.2 higher odds (95%CI 1.3–30; per every 25 μg/L increment) of
having urinary albumin concentrations 430 mg/L (adjusted for
the same co-variates as model 3), and urinary albumin was in-
versely associated with vitamin D3 (p¼0.003) and serum magne-
sium concentrations (p¼0.007).4. Discussion
This longitudinal study suggests, for the ﬁrst time, that elevated
lithium exposure through drinking water may impair the calcium
homeostasis during pregnancy. In particular, a 25 μg/L increment
in blood lithium concentrations (range 1.9–145 μg/L) was asso-
ciated with almost 5 times higher risk of having vitamin D3
concentrations o30 nmol/L (19% of the women). Furthermore,
blood lithium was associated with higher serum magnesium andlower urinary excretion of magnesium and calcium. The associa-
tions were robust and became generally stronger after adjustment
for multiple potential confounders and effect modiﬁers. In con-
trast, we observed no association between blood lithium and PTH
or serum calcium. Interestingly, we found by far the strongest
association of lithium in the women with the highest serum vi-
tamin D3 concentrations (six times stronger association, compared
with those with lowest vitamin D), which might indicate a genetic
variation in susceptibility, e.g. in the vitamin D-binding protein
gene (Powe et al., 2013).
Only few previous studies have measured 25-hydroxyvitamin
D3 concentrations in relation to lithium and all those involved
patients on lithium treatment, i.e. with much higher lithium
concentrations (serum lithium generally 45000 μg/L, corre-
sponding to about 3500 μg/L in whole blood). Three studies (n¼7,
n¼111 and n¼35) found lower 25-hydroxyvitamin D3 con-
centrations in lithium-treated patients compared to controls (Ha-
den et al., 1997; Oliveira et al., 2014; van Melick et al., 2014). Also
in line with the present ﬁndings, clinical studies have shown an
increase in serum magnesium (Transbol et al., 1978) and a de-
crease in urinary calcium concentrations in lithium-treated pa-
tients (Haden et al., 1997; Mak et al., 1998).
The observed inverse association between blood lithium and
vitamin D3 may be explained by different mechanisms. Because
blood lithium was not associated with PTH in the present study,
possibly explained by the known ability of lithium to reset the
calcium “set-point” (Brown, 1981), i.e. the level of serum calcium
at which PTH production is inhibited, non-parathyroid mechan-
isms could be involved. One possibility is that lithium stimulates
the ﬁbroblast growth factor 23 (FGF23), which in turn stimulates
the production of 24-hydroxylase (CYP24A1), essential for the
catabolism of 25-hydroxyvitamin D3 and 1,25-hydroxyvitamin D3
(Fakhri et al., 2014). A stimulation of FGF23 would increase the
urinary excretion of bone minerals (Brannon and Picciano 2011;
Fakhri et al., 2014), supporting our ﬁndings of inverse associations
of blood lithium with urinary calcium, magnesium and phos-
phorus. Another possibility is that the apparent lithium-related
decrease in vitamin D is a consequence of impaired kidney func-
tion, which is a known side effect of lithium therapy (McKnight
et al., 2012). Indeed, we found that a 25 μg/L increment in blood
lithium was associated with 6 times higher adjusted odds of
having urinary albumin above 30 mg/L – a marker of impaired
kidney function (Levey et al., 2015). Impaired kidney function has
previously been associated with lower serum 25-hydroxyvitamin
D3 concentrations (Damasiewicz et al., 2013; de Boer et al., 2011),
in line with the ﬁnding in the present study. The associations of
lithium with magnesium and calcium might be explained by such
a mechanism as well, because the homeostasis of these elements
is mainly regulated by the kidneys (Blaine et al., 2015). In support
to this, we found that also the association between lithium and
serum magnesium was attenuated by urinary albumin. We found
no association between blood lithium and blood pressure in the
women; however, few women (n¼3) had elevated blood pressure.
Further investigations of a potential impact of drinking water li-
thium on kidney function are warranted.
Our ﬁndings have clinical relevance, since low vitamin D3
concentrations during pregnancy may be detrimental for both
maternal and fetal health (Brannon and Picciano, 2011). Particu-
larly, low vitamin D3 concentrations have been associated with
preeclampsia, reduced intrauterine growth, shorter post-natal size
and impaired neurodevelopment (Brannon and Picciano, 2011;
Eckhardt et al., 2015; Moon et al., 2015). In the present study, 58%
of the pregnant women had vitamin D3 concentrations
o50 nmol/L and 19% had concentrations o30 nmol/L, indicating
apparent deﬁciency. Whether a lithium-related impairment of the
vitamin D3 metabolism, possibly in combination with the
F. Harari et al. / Environmental Research 147 (2016) 1–76previously indicated impairment of thyroid function in these wo-
men (Harari et al., 2015b), may explain the observed shorter birth
length in relation to the lithium exposure (Harari et al., 2015b) is
presently unknown.
The ﬁndings of low vitamin D concentrations in this study
population raise the need for a more thorough follow-up of
pregnant women and children in particular. High prevalence (97%)
of vitamin D3 levels o50 nmol/L among children in the same
study area was recently reported (Hirschler et al., 2013). Despite
residing in a high altitude area with plenty of sunlight to enable
endogenous vitamin D production (Wacker and Holick, 2013), the
cold and windy climate of the Puna necessitates much clothing,
leaving small areas of the fairly dark skin to be UVB-exposed. In-
deed, we observed a marked decrease in vitamin D concentrations
from summer to winter, an association independent of lithium.
Similarly low serum vitamin D concentrations have been observed
in elderly women in the highlands of Guatemala (mean
48.4711.6 nmol/L) (Sud et al., 2010) and in Swedish pregnant
women in the 3rd trimester (mean 47.4718 nmol/L) (Brembeck
et al., 2013). Among pregnant women in the U.S., the prevalence of
low serum vitamin D3 levels was higher among Hispanic Amer-
icans and African Americans, compared to Caucasians (Johnson
et al., 2011), demonstrating the inﬂuence of skin pigmentation. In
addition, dietary intake of vitamin D in our study area is likely low
as they lack access to vitamin D-rich food such as oily ﬁsh and
fortiﬁed foods.
The drinking water concentration of lithium varied con-
siderably in the present study area, from 5 to 1660 μg/L) (Concha
et al., 2010; Harari et al., 2015b). Similar lithium concentrations
(1000–2000 μg/L) have been reported for certain areas in Austria
and northern Chile (Kapusta et al., 2011; Zaldivar, 1980), as well as
for several brands of bottled water (Reimann and Birke, 2010).
Lithium concentrations up to about 200 μg/L have been reported
for drinking water in the U.S. (Texas), Greece, Japan, England and
Italy (Pompili et al., 2015; Vita et al., 2015). To note, lithium is
seldom included in the routine drinking water analysis.
The strengths of our study include the population-based
longitudinal design, covering most of the Andean part of the Salta
province, with wide ranges of lithium concentrations in drinking
water. We used multiple biomarkers of calcium homeostasis col-
lected longitudinally across pregnancy along with the measure-
ment of the exposure biomarkers, and evaluated potential me-
chanisms and susceptibility factors. Also, we took special care to
protect the collected blood samples from UV-light, to avoid biased
vitamin D results.
As in all observational studies, our ﬁndings are associations and
do not infer causality. Thus, we cannot rule out the possibility of
residual or unmeasured confounding related to variations in the
vitamin D status. Although the 25-hydroxyvitamin D3 concentra-
tions reﬂect the total exposure from dietary intakes and the en-
dogenous production and are used to assess adequacy (Brannon
and Picciano, 2011), the fact that they are inﬂuenced by factors
such as thyroid hormone concentrations, kidney function and vi-
tamin D receptor polymorphisms (Lips, 2007) makes this marker
less useful to assess calcium homeostasis. Also, there is a lack of
agreement in reference values. However, we carefully evaluated
other potential explanations for the associations observed in re-
lation to lithium exposure and found no indication of such inﬂu-
ence. For example, restricting the analyses to women in the largest
village, who have a more homogeneous lifestyle and ethnicity, did
not change the results. The lack of associations of lithium exposure
with PTH, calcium and phosphorus might have been caused by the
known circadian variations in the plasma concentrations of these
markers (Redmond et al., 2014). Due to the study logistics and the
long distances between villages it was impossible to collect the
samples at a speciﬁc time of the day. Another limitation is the lackof determination of vitamin D-binding protein and various poly-
morphisms, which may inﬂuence the vitamin D levels. Investiga-
tion of these factors is warranted in future follow ups. Also, the
interpretation of the association with serum phosphorus in the
present study is uncertain as our measurements of total phos-
phorus do not only reﬂect the inorganic phosphate. Finally, the
cohort was fairly small and we did not manage to obtain samples
for all women at all time-points. Thus, the ﬁndings need to be
followed-up in larger studies and in other populations.5. Conclusions
Our study suggests that elevated lithium exposure through
drinking water during pregnancy may impair the calcium home-
ostasis, particularly vitamin D. If conﬁrmed, our ﬁndings are of
public health relevance and reinforce the need for better control of
drinking water sources, including bottled water.Competing ﬁnancial interest declaration
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